Global Resource for Advancing Cancer Education – Trademark Portfolio
Entity Type: 99
Global Resource for Advancing Cancer Education holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 44 (Medical Services) — 3 filings in this category. Currently, 2 trademarks are registered. Notable registered marks include GRACE and GLOBAL RESOURCE FOR ADVANCING CANCER EDUCATION. The owner is based in Seattle, WA.
4616 25th Ave. NE, #300
Seattle, WA 98105
Showing of trademarks Trademarks
Trademark Classifications
Global Resource for Advancing Cancer Education's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does Global Resource for Advancing Cancer Education have?
Global Resource for Advancing Cancer Education has 3 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 cancelled.
What trademark classes does Global Resource for Advancing Cancer Education file in?
Global Resource for Advancing Cancer Education files trademarks across 1 Nice Classification class. The most active classes are Class 44 (Medical Services). Class 44 covers medical services; veterinary services; hygienic and beauty care for human beings or animals.
What are Global Resource for Advancing Cancer Education's most well-known trademarks?
Global Resource for Advancing Cancer Education's registered trademark portfolio includes well-known marks such as GRACE and GLOBAL RESOURCE FOR ADVANCING CANCER EDUCATION. These are among 2 currently registered trademarks in the portfolio.
What is Global Resource for Advancing Cancer Education's trademark registration success rate?
Global Resource for Advancing Cancer Education has a 67% trademark registration rate, with 2 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.